New Drug Production Proposed for Foreign-Trade Zone in North Carolina

You might care about this because the US government is announcing a notice about a pharmaceutical company called Patheon Manufacturing Services LLC. This company wants to produce specific medicines within a special area called a Foreign-Trade Zone (FTZ) in Greenville, North Carolina. The notice is about their plan to make Opdualag, a drug used to treat melanoma and other cancers, using ingredients like Relatlimab and Nivolumab. These ingredients are foreign-status, meaning they come from outside the US. Operating in an FTZ can offer certain advantages, like how duties on imported materials are handled. The Foreign-Trade Zones Board received this request on May 14, 2026. This announcement is part of the process where the public can comment on the company's proposed production activities. The rules for this kind of activity limit what can be produced and what materials can be used, based on the company's application. This notice explains what Patheon plans to do and invites public feedback before a final decision is made. What makes this interesting is how the Foreign-Trade Zone system works for companies like Patheon. When a company operates within an FTZ, it can manage import duties differently. For example, if they bring in foreign materials to make a product that will then be exported, they might not have to pay duties on those materials. If the finished product is sold in the US, duties are paid on the finished product, not on the individual parts, which can sometimes result in lower overall costs. This particular request highlights specific drugs, Opdualag, and its components, Relatlimab and Nivolumab. Some of these materials might normally be subject to special duties under Section 301 of the Trade Act of 1974. However, by admitting them into the FTZ under 'privileged foreign status,' the company can ensure how those duties are calculated and managed. This offers a way for companies to streamline their manufacturing process and manage costs, especially when dealing with global supply chains for critical medicines. It shows how specific trade regulations can affect the production of important health treatments. People who would find this document particularly relevant include pharmaceutical companies, especially those involved in manufacturing complex biologics or cancer treatments. Companies that import materials for production in the US would also be interested in how Foreign-Trade Zones can help manage duties and supply chain logistics. Legal professionals specializing in international trade law, customs regulations, or intellectual property in pharmaceuticals would also find this case useful for understanding practical applications of trade policies. Economic development agencies in areas with FTZs, such as Greenville, North Carolina, would pay attention to such announcements as they indicate new or expanded production activities. Finally, patients and healthcare providers who depend on medicines like Opdualag might also have an indirect interest, as these operational details can influence the availability and cost of critical drugs.